Q1 2021 Reporting

Highlights

  • Australian ethical committee approved the information about next clinical study SER150 CL-009
  • Six clinical centers were approved to be involved in SER150 CL-009
  • The Covid19 pandemic has continued to influence all communication between the Clinical research laboratories and Serodus

Go to the report: Serodus ASA QR 2021-Q1